References
- FintakDRGauravKSBlinderKJIncidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabRetina2008281395139918827737
- StepienKEEatonAMJaffeGJIncreased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006Retina20092920721319050670
- RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging20053633133516156152
- GreenbergPBMartidisARogersAHDukerJSReichelEIntravitreal triamcinolone for the treatment of macular oedema due to central retinal vein occlusionBr J Ophthalmol20028624724811815359
- HeierJSAntoszykANPavanPRRanibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose studyOphthalmology200611363364216483659
- SchwartzSGFlynnHWScottIUEndophthalmitis after intravitreal injectionsExpert Opin Pharmacother2009132119212619586422
- MasonJOMiltonFWFeistRMIncidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injectionRetina20082856456718398358
- KleinKSWalshMKHassanTSEndophthalmitis after anti-VEGF injectionsOphthalmology2009116122519486799
- BhavsarARGoogeJMStockdaleCRRisk of endophthalmitis after intravitreal drug injection when topical antibiotics are not requiredArch Ophthalmology200912715811583
- DiagoTMcCannelCABakriSJPulidoJSEdwardsAOPachJMInfectious endophthalmitis after intravitral injection of antiangiogenic agentsRetina20092960160519357558
- GragoudasESAdamisAPCunninghamETPegaptanib for neovascular age-related macular degenerationN Engl J Med20043512805281615625332
- JonasJBSpandauUHRenschFVon BaltzSSchlichtenbredeFInfectious and noninfectious endophthalmitis after intravitreal bevacizumabJ Ocul Pharmacol Ther20072324024217593007
- ArtunayOYuzbasiogluERasierRSengülABahceciogluHIncidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injectionEye2009232187219319218994
- RosenfeldPJBrownMDHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
- JonasJBKreissingISpandauUHHarderBInfectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideAm J Ophthalmol200614157958016490517
- RothDBFlynnHWDistinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injectionAm J Ophthalmol200814634634718724979
- DoftBHThe Endophthalmitis Vitrectomy StudyArch Ophthalmol19911094874892012545
- FlynnHWScottIULegacy of the Vitrectomy StudyArch Ophthalmol200812655956118413530
- ScottIUFlynnHWSundeepDEndophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomesRetina20082813814218185150
- AielloLPBruckerAJChangSCunninghamETEvolving guidelines for intravitreal injectionsRetina2004S31915483476
- SpeakerMGMenikoffJAProphylaxis of endophthalmitis with povidone-iodineOphthalmology199198176917751775308
- ScottIUFlynnHWThe role of topical antibiotic prophylaxis for intravitreal injectionsArch Ophthalmol200712597497617620584